Fig. 2From: Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trialA Osteogenic and B adipogenic differentiation of hUC-MSCs (magnification ×100 (A) and ×400 (B) from inverted phase microscope). hUC-MSCs human umbilical cord-derived mesenchymal stromal cellsBack to article page